# The Clinical Research of the Safety and Effectiveness Evaluation for Using Echocardiography-guided Liwen RF Radiofrequency Ablation System to Treat Hypertrophic Obstructive Cardiomyopathy

> **NCT04355260** · NA · UNKNOWN · sponsor: **Xijing Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Hypertrophic Obstructive Cardiomyopathy

## Interventions

- **PROCEDURE:** Echocardiography-guided Radiofrequency ablation for Hypertrophic obstructive Cardiomyopathy (HOCM).

## Key facts

- **NCT ID:** NCT04355260
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-07-30
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-07-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2021-01-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04355260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04355260, "The Clinical Research of the Safety and Effectiveness Evaluation for Using Echocardiography-guided Liwen RF Radiofrequency Ablation System to Treat Hypertrophic Obstructive Cardiomyopathy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04355260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*